Active components of ginkgo biloba may help to improve early cognitive recovery after having a stroke, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2024.
The preliminary study treated adults who experienced an ischemic (clot-caused) stroke with 14 days of intravenous injections of ginkgo diterpene lactone meglumine (GDLM), which is a combination of biologically active component of ginkgo biloba. Findings showed that the patients who were treated within the first two weeks after the stroke had better cognitive recovery at 14 and 90 days.
In 2023 the same researchers published results from a multicenter trial in China showing that those who experienced an ischemic stroke had better recovery from overall stroke symptoms if they were treated with daily injections of GDLM. The current study also analyzed the cognitive recovery of participants of this previous study.
